Postpartum Care Practice Questions

Q: Misoprostol has been found to be effective in all of the following, EXCEPT:

Menorrhagia. **Explanation:** **Misoprostol** is a synthetic **Prostaglandin E1 (PGE1) analogue**. Its primary pharmacological actions include stimulating uterine contractions (oxytocic effect) and softening the cervix (cervical ripening). **Why Menorrhagia is the Correct Answer:** Menorrhagia (heavy menstrual bleeding) is primarily managed by reducing menstrual blood flow through antifibrinolytics (Tranexamic acid), NSAIDs, or hormonal therapy (OCPs, Progestogens, or LNG-IUS). Misoprostol causes uterine contractions but does not effectively reduce the volume of menstrual blood loss; therefore, it has no clinical role in treating menorrhagia. **Analysis of Other Options:** * **Medical Method of Abortion (MMA):** Misoprostol is used in combination with Mifepristone. It induces uterine contractions to expel the products of conception. * **Induction of Labor:** It is used for cervical ripening and induction, especially in cases of intrauterine fetal death (IUFD) or when the Bishop score is unfavorable. * **Prevention of PPH:** According to WHO guidelines, 600 µg of oral Misoprostol is an effective alternative for the active management of the third stage of labor (AMTSL) when injectable Oxytocin is unavailable. **High-Yield Clinical Pearls for NEET-PG:** * **Route of Administration:** Misoprostol can be given orally, sublingually, vaginally, or rectally. Sublingual has the fastest onset. * **PPH Dosage:** 600 µg orally for prevention; 800 µg sublingually for treatment. * **Side Effects:** The most common side effects are **shivering and pyrexia** (fever). * **Contraindication:** Avoid for induction of labor in women with a previous cesarean section due to the high risk of **uterine rupture**.

Q: Which of the following drugs is not commonly used in the management of postpartum hemorrhage (PPH)?

Mifepristone. **Explanation:** The management of Postpartum Hemorrhage (PPH) focuses on achieving uterine contraction (uterotonics) to compress the spiral arteries. **Why Mifepristone is the correct answer:** **Mifepristone** is a competitive **progesterone receptor antagonist**. It is primarily used for the medical termination of pregnancy (MTP) and cervical ripening because it softens the cervix and increases uterine sensitivity to prostaglandins. It does not cause the immediate, sustained uterine contractions required to arrest acute bleeding in PPH. Therefore, it has no role in the emergency management of PPH. **Analysis of Incorrect Options:** * **Oxytocin:** The **first-line drug** for both prophylaxis (AMTSL) and treatment of PPH. It acts on G-protein coupled receptors to cause rhythmic uterine contractions. * **Misoprostol (Prostaglandin E1):** A stable PGE1 analogue often used in PPH management (dose: 600–800 mcg) via sublingual, oral, or rectal routes, especially in low-resource settings. * **Ergotamine/Methylergometrine:** Ergot alkaloids cause tetanic uterine contractions. **Methergine** (0.2 mg IM) is a standard second-line agent but is strictly contraindicated in patients with hypertension or pre-eclampsia. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for PPH Prophylaxis:** Oxytocin (10 IU IM/IV). * **Carbetocin:** A long-acting oxytocin agonist now recommended by WHO for PPH prevention in settings where the cold chain can be maintained. * **PGF2α (Carboprost):** Highly effective for refractory PPH but **contraindicated in Asthmatics**. * **Tranexamic Acid (TXA):** An antifibrinolytic that should be administered within 3 hours of birth in all cases of PPH (WOMAN Trial).

Q: Puerperal sepsis can occur up to what time period after childbirth?

6 weeks. ### Explanation **1. Understanding the Correct Answer (D. 6 weeks)** Puerperal sepsis is defined as an infection of the genital tract occurring at any time between the onset of rupture of membranes or labor and the **42nd day (6 weeks)** following childbirth or abortion. This timeframe corresponds exactly with the **Puerperium**, the period during which the maternal reproductive organs return to their pre-pregnancy state. Any infection manifesting within this window is clinically classified as puerperal sepsis, provided two or more of the following are present: pelvic pain, fever (38.5°C or higher), abnormal vaginal discharge, or delay in the rate of reduction of the size of the uterus (subinvolution). **2. Why Other Options are Incorrect** * **Options A, B, and C (1, 2, and 3 weeks):** While the majority of puerperal infections manifest early (typically within the first 10 days), the clinical and legal definition extends to the full duration of the puerperium. Restricting the diagnosis to 1–3 weeks would fail to account for late-onset infections, such as those caused by retained products of conception or secondary postpartum hemorrhage (PPH) leading to late sepsis. **3. High-Yield Clinical Pearls for NEET-PG** * **Most Common Organism:** *Streptococcus pyogenes* (Group A Strep) is historically the most significant, though infections are often polymicrobial (including *E. coli*, *Staphylococcus*, and anaerobes). * **Most Common Site:** The **endometrium** (Endometritis) is the most common site of infection. * **Risk Factors:** Cesarean section is the single most important risk factor for puerperal sepsis. * **Diagnosis:** Fever in the puerperium is defined as a temperature of 38.0°C (100.4°F) or higher on any two of the first ten days postpartum (excluding the first 24 hours).

Q: A 2-year-old child's mother presents with a 40-week pregnancy, complaining of vulvar pruritus and amenorrhea. She reports severe blood loss and failure of lactation during her previous pregnancy. She is lethargic, has cold intolerance, multiple skin infections, and anemia. What is the most likely diagnosis?

Sheehan's syndrome. **Explanation:** The clinical presentation points towards **Sheehan’s syndrome**, which is postpartum pituitary necrosis resulting from severe obstetric hemorrhage and hypovolemic shock. **Why Sheehan’s syndrome is correct:** During pregnancy, the pituitary gland enlarges (hypertrophy of lactotrophs), making it highly susceptible to ischemia. Severe blood loss during the previous delivery (as mentioned in the history) leads to infarction of the anterior pituitary. This results in **panhypopituitarism**: * **Failure of lactation:** Due to Prolactin deficiency (earliest sign). * **Amenorrhea:** Due to Gonadotropin (FSH/LH) deficiency. * **Lethargy and Cold Intolerance:** Due to secondary hypothyroidism (TSH deficiency). * **Skin infections and Anemia:** Due to ACTH deficiency (low cortisol) and general hormonal imbalance. **Why other options are incorrect:** * **Asherman’s syndrome:** This involves intrauterine adhesions (synechiae) usually following over-zealous curettage. While it causes secondary amenorrhea, it does **not** cause systemic symptoms like cold intolerance, failure of lactation, or lethargy. * **Prolactinoma:** This would cause galactorrhea (excessive milk production) and amenorrhea, which contradicts this patient’s failure to lactate. **High-Yield Clinical Pearls for NEET-PG:** * **Earliest clinical sign:** Failure of lactation (Agalactia). * **Most common initial symptom:** Secondary amenorrhea or oligomenorrhea. * **Diagnosis:** Gold standard is MRI (shows "Empty Sella" in late stages); biochemically, there are low levels of pituitary hormones (TSH, ACTH, FSH, LH, Prolactin). * **Management:** Lifelong hormone replacement therapy (Cortisones, Thyroxine, and Estrogen/Progesterone). Always replace corticosteroids *before* thyroxine to avoid precipitating an adrenal crisis.

Q: All of the following are used in the management of PPH except?

NOVO-T. **Explanation:** The management of Postpartum Hemorrhage (PPH) focuses on hemodynamic stabilization, replacement of clotting factors, and surgical/mechanical interventions to control bleeding. **Why NOVO-T is the correct answer:** **NOVO-T** is a brand of **Intrauterine Device (IUD)** used for contraception. It has no role in the management of acute PPH. In fact, the presence of a foreign body like an IUD could interfere with uterine contractions (uterine atony), which is the most common cause of PPH. **Analysis of other options:** * **Blood (Whole Blood/PRBCs):** Essential for restoring oxygen-carrying capacity and intravascular volume in massive hemorrhage. * **FFP (Fresh Frozen Plasma):** Contains all coagulation factors. It is indicated when there is a deficiency of multiple clotting factors or during massive transfusion protocols (MTP) to prevent dilutional coagulopathy. * **Cryoprecipitate:** Rich in Fibrinogen, Factor VIII, Factor XIII, and von Willebrand factor. It is specifically used when fibrinogen levels drop below 100–150 mg/dL. **High-Yield Clinical Pearls for NEET-PG:** * **Definition of PPH:** Blood loss >500 ml (Vaginal) or >1000 ml (LSCS). * **Most Common Cause:** Uterine Atony (70%). * **Drug of Choice (Prophylaxis & Treatment):** Oxytocin. * **Massive Transfusion Protocol (MTP) Ratio:** Usually 1:1:1 (PRBC:FFP:Platelets). * **Surgical Management:** If medical management fails, options include uterine artery embolization, B-Lynch sutures, or internal iliac artery ligation. * **Note:** Do not confuse **NOVO-T** with **NovoSeven** (Recombinant Factor VIIa), which *is* used in refractory PPH.

Q: Postpartum hemorrhage is present when blood loss exceeds:

500 c.c.. **Explanation:** Postpartum Hemorrhage (PPH) is traditionally defined based on the volume of blood loss within 24 hours following childbirth. The correct answer is **500 c.c.** because this is the internationally recognized threshold for PPH following a **vaginal delivery**. **Why the correct answer is right:** According to the WHO and standard textbooks like Williams Obstetrics and Dutta’s Textbook of Gynecology, PPH is defined as blood loss ≥500 mL after vaginal delivery or ≥1000 mL after a Cesarean section. This volume is clinically significant because it exceeds the physiological blood loss expected during the third stage of labor and can begin to compromise maternal hemodynamics. **Analysis of incorrect options:** * **A (200 c.c.) & B (400 c.c.):** These volumes are considered within the physiological range for a normal vaginal delivery. While any bleeding should be monitored, they do not meet the diagnostic criteria for PPH. * **D (700 c.c.):** While this amount is indeed a hemorrhage, the *threshold* for diagnosis starts at 500 c.c. Waiting until 700 c.c. to diagnose PPH would delay life-saving interventions. **NEET-PG High-Yield Pearls:** * **Most Common Cause:** Uterine Atony (70-80% of cases). * **Updated Definition:** Many modern guidelines (like ACOG) now define PPH as cumulative blood loss **≥1000 mL** regardless of the route of delivery, OR blood loss accompanied by signs/symptoms of hypovolemia. However, for exam purposes, the **500 mL (Vaginal) / 1000 mL (LSCS)** rule remains the standard. * **Primary vs. Secondary:** Primary PPH occurs within 24 hours; Secondary PPH occurs between 24 hours and 12 weeks postpartum (most common cause: retained products of conception). * **First-line Management:** Uterine massage and Oxytocin (Drug of Choice).

Question 1

Misoprostol has been found to be effective in all of the following, EXCEPT:

Accepted Answer

Menorrhagia

Answer

Medical method of abortion

Answer

Induction of labor

Answer

Prevention of postpartum hemorrhage (PPH)

Question 2

Which of the following drugs is not commonly used in the management of postpartum hemorrhage (PPH)?

Accepted Answer

Mifepristone

Answer

Misoprostol

Answer

Oxytocin

Answer

Ergotamine

Question 3

Which of the following terms is used to describe the process in which the uterus contracts and atrophies to its nonpregnant size?

Accepted Answer

Involution

Answer

Reparation

Answer

Contracture

Answer

Decompression

Question 4

Puerperal sepsis can occur up to what time period after childbirth?

Accepted Answer

6 weeks

Answer

1 week

Answer

2 weeks

Answer

3 weeks

Question 5

In normal puerperium, which of the following is NOT true regarding involution of the uterus?

Accepted Answer

At the end of the 4th week, the uterus becomes a pelvic organ.

Answer

At the end of 6 weeks, the uterus returns to its non-pregnant state.

Answer

The number of muscle fibers does not decrease, but there is a substantial reduction in myometrial cell size.

Answer

The weight of the uterus is about 60 grams at the end of six weeks.

Question 6

A 2-year-old child's mother presents with a 40-week pregnancy, complaining of vulvar pruritus and amenorrhea. She reports severe blood loss and failure of lactation during her previous pregnancy. She is lethargic, has cold intolerance, multiple skin infections, and anemia. What is the most likely diagnosis?

Accepted Answer

Sheehan's syndrome

Answer

Asherman's syndrome

Answer

Prolactinoma

Answer

None of the above

Question 7

Which of the following is not used in postpartum hemorrhage?

Accepted Answer

PGE1

Answer

PGF2α

Answer

PGE2

Answer

Ergometrine

Question 8

All of the following are used in the management of PPH except?

Accepted Answer

NOVO-T

Answer

Blood

Answer

FFP

Answer

Cryoprecipitate

Question 9

Which of the following conditions necessitates a hysterectomy in the postpartum period?

Accepted Answer

Postpartum hemorrhage not controlled by ligation of the internal iliac artery

Answer

Twin pregnancy

Answer

Endometriosis

Answer

Fibroid uterus

Question 10

Postpartum hemorrhage is present when blood loss exceeds:

Accepted Answer

500 c.c.

Answer

200 c.c.

Answer

400 c.c.

Answer

700 c.c.

Postpartum Care — MCQs

Postpartum Care — MCQs

On this page

Practice by Chapter

Want unlimited practice?